Search
Search Results
##search.searchResults.foundPlural##
-
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1046PDF: 1224Suppl. Files: 146HTML: 69 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12345PDF: 1679HTML: 4169Cover letter: 197Figure 1: 204 -
The significance of purity: Leukaemias involving the erythroid lineage Erythroid lineage leukemia
806PDF: 422HTML: 285 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2030PDF: 823HTML: 212 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1184PDF: 783HTML: 218 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3192PDF: 1580HTML: 258 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2669PDF: 967HTML: 4703 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4726PDF: 1554HTML: 2251Untitled: 207Untitled: 222Untitled: 230Untitled: 213Untitled: 216 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
956PDF: 583HTML: 340 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1101PDF: 542HTML: 1690Figures: 167Fifures Sanz: 176tables Sanz: 180Untitled: 176 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3366PDF: 1280HTML: 2215Fi.1 Gritti.Rambaldi: 205 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3270PDF: 1238HTML: 8105 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3134PDF: 1825HTML: 3569 -
Anemia in the elderly: not always what it seems.
3309PDF: 1034HTML: 1774Figure 1: 176Figure 1 revised: 179 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1831PDF: 716HTML: 2106Untitled: 216Untitled: 152Untitled: 171Untitled: 154Untitled: 163Untitled: 178Untitled: 183 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4318PDF: 1489HTML: 1547Untitled: 225 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2190PDF: 929HTML: 409Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 213UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 341Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 240Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 176Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 188Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 257 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1300PDF: 1081PDF: 864HTML: 159 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
940PDF: 573HTML: 2193Cover Letter: 190 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3263PDF: 1534HTML: 421 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2448PDF: 1301HTML: 1751CoverLetter: 180 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1940PDF: 1164HTML: 266 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1618PDF: 898HTML: 1877Untitled: 195Untitled: 179 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
980PDF: 450HTML: 134 -
WHAT ARE FUNGAL INFECTIONS?
4179PDF: 2375HTML: 27593de Pauw: 235 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3678PDF: 1283HTML: 728Figure 2: 452Figure 1: 3117







